Adenomyosis: Genomic Mechanisms and Biological Response

The University of Texas System (UT)

Status: Withdrawn

Conditions: Adenomyosis; Abnormal Uterine Bleeding

Treatments: Drug: LNG-IUS

Study type: Observational

Funder types: Other

Identifiers

NCT03428854

0000

Details and patient eligibility

About

Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.

Full description

Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.

Sex: Female

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Abnormal bleeding in the presence of Adenomyosis as demonstrated by MRI

Exclusion criteria

• Other causes of abnormal bleeding such as fibroids, endometrial polyps, malignancy
• Presence of endometriosis